[PR Newswire] - SEATTLE, March 1, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment